Rpo »

Lexicon Pharmaceuticals shares owned by Rpo

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by Rpo from 13F filings

Historical chart of Rpo investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by Rpo consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by Rpo

Quarter filed Position value Share count Share price at filing
2023-12-31 $49k 32k 1.53

More positions owned by Rpo

stock
Abrdn Healthcare Investors Sh Ben Int (HQH)
Nuveen Multi-Strategy Income & Growth (JPC)
Abrdn Life Sciences Investor Sh Ben Int (HQL)
Flaherty & Crumrine/Claymore Preferred S (FFC)
Blackrock Science & Technolo Shs Ben Int (BSTZ)
Flaherty & Crumrine Dynamic SHS (DFP)
Gabelli Dividend & Income Trust (GDV)
Blackrock Muniyield Fund (MYD)
Calamos Global Dynamic Income Fund (CHW)
Duff & Phelps Global (DPG)
Royce Value Trust (RVT)
Blackrock Munivest Fund II (MVT)
Boulder Growth & Income Fund (STEW)
Capri Holdings SHS (CPRI)

View all positions for Rpo

Top funds holding Lexicon Pharmaceuticals

Artal Group
BVF
Vanguard Group
Jpmorgan Chase & Co
NEA Management Company
Gail Mannix
Millennium Management
Citadel Advisors
Charles Schwab Investment Management
GSA Capital Partners
D. E. Shaw & Co
Bank of New York Mellon
Connor, Clark & Lunn Investment Management
Jane Street
Virtus ETF Advisers

View all funds holding Lexicon Pharmaceuticals